The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
D000480:Alkynes / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D003641:Deamination; D004305:Dose-Response Relationship, Drug; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010084:Oxidation-Reduction; D010627:Phenethylamines / Q000378:metabolism / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D010870:Pineal Gland / Q000378:metabolism; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D014363:Tryptamines / Q000378:metabolism*
D000480:Alkynes; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D010647:Phenyl Ethers; D011437:Propylamines; D014363:Tryptamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008995:Monoamine Oxidase